支持和反对血糖变异性在糖尿病并发症发生中作用的论据。
Arguments for and against the role of glucose variability in the development of diabetes complications.
作者信息
Kilpatrick Eric S
机构信息
Department of Clinical Biochemistry, Hull Royal Infirmary, Hull, United Kingdom.
出版信息
J Diabetes Sci Technol. 2009 Jul 1;3(4):649-55. doi: 10.1177/193229680900300405.
Abstract
There is now unequivocal evidence that improving glycemic control in both type 1 and type 2 diabetes reduces the likelihood of developing the micro- and macrovascular complications of the disease. However, it is still unclear whether a patient with very variable glucose is at any different a risk of these problems than someone who has the same mean glucose but much more stable glycemia. This article reviews the evidence that exists to both support and refute the claim that increased glucose variability should be regarded as an independent risk factor for the development of diabetic vascular disease.
摘要
现在有明确的证据表明，改善1型和2型糖尿病患者的血糖控制可降低发生该疾病微血管和大血管并发症的可能性。然而，血糖波动很大的患者与平均血糖相同但血糖更稳定的患者相比，发生这些问题的风险是否存在差异仍不清楚。本文综述了支持和反驳以下观点的现有证据：血糖变异性增加应被视为糖尿病血管疾病发生的独立危险因素。
相似文献
1
Arguments for and against the role of glucose variability in the development of diabetes complications.支持和反对血糖变异性在糖尿病并发症发生中作用的论据。
J Diabetes Sci Technol. 2009 Jul 1;3(4):649-55. doi: 10.1177/193229680900300405.
2
For debate. Glucose variability and diabetes complication risk: we need to know the answer.争议中。血糖变异性与糖尿病并发症风险：我们需要知道答案。
Diabet Med. 2010 Aug;27(8):868-71. doi: 10.1111/j.1464-5491.2010.02929.x.
3
Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.血糖变异性与糖尿病患者并发症：系统文献回顾的证据。
Diabetes Obes Metab. 2010 Apr;12(4):288-98. doi: 10.1111/j.1463-1326.2009.01160.x.
4
Postprandial glycemia and cardiovascular disease in diabetes mellitus.糖尿病中的餐后血糖与心血管疾病
Arq Bras Endocrinol Metabol. 2007 Mar;51(2):212-21. doi: 10.1590/s0004-27302007000200010.
5
The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes.血糖控制对2型糖尿病大血管并发症发生率的影响。
Arch Fam Med. 1998 Mar-Apr;7(2):155-62. doi: 10.1001/archfami.7.2.155.
6
Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.关于高血糖及血糖控制改善对2型糖尿病大血管事件影响的流行病学研究。
Diabetes Care. 1999 Apr;22 Suppl 3:C54-6.
7
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial.在 2 型糖尿病中，血糖变异性对大血管和微血管事件及全因死亡率的影响： ADVANCE 试验。
Diabetes Care. 2014 Aug;37(8):2359-65. doi: 10.2337/dc14-0199. Epub 2014 May 8.
8
Tachykinins Play a Major Role in Micro and Macrovascular Complications in Type 2 Diabetes Patients.速激肽在 2 型糖尿病患者的微血管和大血管并发症中起主要作用。
Curr Diabetes Rev. 2024;20(3):e050523216590. doi: 10.2174/1573399819666230505123844.
9
The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus.强化血糖控制对预防糖尿病血管并发症的有效性。
Treat Endocrinol. 2006;5(5):273-86. doi: 10.2165/00024677-200605050-00002.
10
Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.2型糖尿病患者基础血糖和餐后血糖升高对微血管及大血管并发症的影响
Curr Med Res Opin. 2005 Jul;21(7):989-98. doi: 10.1185/030079905x49662.
引用本文的文献
1
Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept.用于远程监测 HbA1c 和血糖变异性的非侵入性可穿戴设备：概念验证。
BMJ Open Diabetes Res Care. 2021 Jun;9(1). doi: 10.1136/bmjdrc-2020-002027.
2
Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability.血糖波动导致糖尿病并发症中的内皮功能障碍和血小板过度激活。
Horm Metab Res. 2022 Jul;54(7):419-428. doi: 10.1055/a-1880-0978. Epub 2022 Jul 14.
3
Non-Invasive Assessment of Metabolic Adaptation in Paediatric Patients Suffering from Type 1 Diabetes Mellitus.1型糖尿病患儿代谢适应性的无创评估
J Clin Med. 2019 Oct 26;8(11):1797. doi: 10.3390/jcm8111797.
4
Insulin Pump Adherence Behaviors Do Not Correlate With Glycemic Variability Among Youth With Type 1 Diabetes (T1D).胰岛素泵依从行为与1型糖尿病（T1D）青少年的血糖变异性无关。
J Diabetes Sci Technol. 2019 Jan;13(1):142-143. doi: 10.1177/1932296818805748. Epub 2018 Oct 13.
5
Longitudinal assessment of hippocampus structure in children with type 1 diabetes.1型糖尿病患儿海马结构的纵向评估。
Pediatr Diabetes. 2018 Apr 19. doi: 10.1111/pedi.12683.
6
Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study.速效胰岛素类似物在1型糖尿病患者中的临床疗效与安全性：一项全国性观察性队列研究
Diabetes Ther. 2016 Sep;7(3):561-73. doi: 10.1007/s13300-016-0191-x. Epub 2016 Aug 12.
7
Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin.四点餐前血糖自我监测用于评估胰岛素和维格列汀治疗的2型糖尿病患者的血糖控制及变异性
Int J Endocrinol. 2015;2015:484231. doi: 10.1155/2015/484231. Epub 2015 Oct 26.
8
Utility of different glycemic control metrics for optimizing management of diabetes.不同血糖控制指标在优化糖尿病管理中的作用。
World J Diabetes. 2015 Feb 15;6(1):17-29. doi: 10.4239/wjd.v6.i1.17.
9
Sleep apnea, sleep disturbance, and fasting glucose variability: a pilot study.睡眠呼吸暂停、睡眠障碍与空腹血糖变异性：一项初步研究。
J Diabetes Sci Technol. 2013 May 1;7(3):743-8. doi: 10.1177/193229681300700320.
10
Evaluation of a minimally invasive system for measuring glucose area under the curve during oral glucose tolerance tests: usefulness of sweat monitoring for precise measurement.用于评估口服葡萄糖耐量试验期间葡萄糖曲线下面积的微创系统：汗液监测对精确测量的实用性
J Diabetes Sci Technol. 2013 May 1;7(3):678-88. doi: 10.1177/193229681300700313.
本文引用的文献
1
The median is not the only message: a clinician's perspective on mathematical analysis of glycemic variability and modeling in diabetes mellitus.中位数并非唯一要点：临床医生对血糖变异性数学分析及糖尿病建模的观点
J Diabetes Sci Technol. 2009 Jan;3(1):3-11. doi: 10.1177/193229680900300102.
2
Glucose control and vascular complications in veterans with type 2 diabetes.2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
3
Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?通过自我血糖监测计算得出的血糖变异性能否预测1型糖尿病患者在十年间并发症的发生情况？
Diabetes Metab. 2008 Dec;34(6 Pt 1):612-6. doi: 10.1016/j.diabet.2008.04.005. Epub 2008 Sep 27.
4
10-year follow-up of intensive glucose control in type 2 diabetes.2型糖尿病强化血糖控制的10年随访
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
5
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.1型糖尿病患者的糖化血红蛋白（A1C）变异性与微血管并发症风险：来自糖尿病控制与并发症试验的数据
Diabetes Care. 2008 Nov;31(11):2198-202. doi: 10.2337/dc08-0864. Epub 2008 Jul 23.
6
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
7
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
8
Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.血糖暴露对糖尿病控制与并发症试验中微血管并发症风险的影响——再探讨
Diabetes. 2008 Apr;57(4):995-1001. doi: 10.2337/db07-1618. Epub 2008 Jan 25.
9
Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes.2型糖尿病患者在家中测得的餐后血糖峰值与颈动脉内膜中层厚度相关。
J Clin Endocrinol Metab. 2008 Apr;93(4):1345-50. doi: 10.1210/jc.2007-2000. Epub 2008 Jan 15.
10
Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes.1型糖尿病患者中，平均血糖与糖化血红蛋白在预测心血管疾病方面的比较。
Diabetologia. 2008 Feb;51(2):365-71. doi: 10.1007/s00125-007-0883-x. Epub 2007 Nov 27.
Zotero 插件